Work

A Phase II Study of High Dose Lenalidomide as Initial Therapy for Acute Myeloid Leukemia in Patients > 60 Years Old.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.842.842

Authors: Ravi Vij, Alissa Nelson, Geoffrey L. Uy, Camille Abboud, Peter Westervelt, Amanda F Cashen, Stockerl-Goldstein Keith, Kathryn M Trinkhaus, John F. DiPersio, Todd A Fehniger

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601429049

FWCI: 0.877

Cites:

Cited by: 5

Related to: 10